These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 16226518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Juvenile idiopathic arthritis-associated uveitis: incidence of ocular complications and visual acuity loss.
    Thorne JE, Woreta F, Kedhar SR, Dunn JP, Jabs DA.
    Am J Ophthalmol; 2007 May; 143(5):840-846. PubMed ID: 17362866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity.
    Thorne JE, Wittenberg S, Jabs DA, Peters GB, Reed TL, Kedhar SR, Dunn JP.
    Ophthalmology; 2006 Dec; 113(12):2310-6. PubMed ID: 16996607
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
    Lai TY, Chan RP, Chan CK, Lam DS.
    Eye (Lond); 2009 Mar; 23(3):543-8. PubMed ID: 18369377
    [Abstract] [Full Text] [Related]

  • 7. Vogt-Koyanagi-Harada disease in Thai patients.
    Tesavibul N, Sansanayuth W.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S26-30. PubMed ID: 16681048
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.
    Paredes I, Ahmed M, Foster CS.
    Ocul Immunol Inflamm; 2006 Apr; 14(2):87-90. PubMed ID: 16597537
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
    Chee SP, Jap A, Bacsal K.
    Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Choroidal folds in acute Vogt-Koyanagi-Harada disease.
    Zhao C, Zhang M, Wen X, Dong F, Han B, Du H.
    Ocul Immunol Inflamm; 2009 Jan; 17(4):282-8. PubMed ID: 19657984
    [Abstract] [Full Text] [Related]

  • 15. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE, Jabs DA, Kempen JH, Holbrook JT, Nichols C, Meinert CL, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease.
    Chee SP, Jap A.
    Br J Ophthalmol; 2013 Feb; 97(2):130-3. PubMed ID: 23212203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.